60°
The symposium is free and open to the public, and lunch will be provided. The Pancreatic Cancer Symposium seeks to educate individuals about the risk factors, early detection options, and treatment updates for pancreatic cancer. Additionally, speakers will highlight supportive care services and dietary information.
Pancreatic cancer currently has a five-year survival rate of just 7 percent, according to the Lustgarten Foundation. Current treatment options for pancreatic cancer include surgery, chemotherapy, and radiation therapy. Researchers are exploring more effective diagnoses and new treatments – including chemotherapy combinations, targeted therapies, and other options for patients with the disease.
According to Dr. Raff, “The low survival rates that we typically see with Pancreatic Cancer are probably due in part to advanced stage at presentation, plus very diverse molecular triggers. In addition to better understanding – and hopefully targeting – the unique molecular framework of these tumors, we believe that early detection may be possible, especially for those at elevated risk.”
White Plains Hospital offers a Pancreatic Cancer Early Detection Program for people at high risk for pancreatic cancer. This clinical trial uses personal and family history, plus available genetic tests, to assess for elevated risk; endoscopic ultrasound and MRI are used as tests for potential early detection.
To register for the symposium or request more information, call (914) 681-1119.
See Attachment